Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants, in which a weekly dose of semaglutide ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement ...

Men are more likely than women to die from high blood pressure, diabetes and HIV/AIDS, after shrugging off medical care for ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

"Ozempic feet" is a side effect of taking GLP-1 medications for weight loss. Here's why it happens and what you can do.

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...